WallStreetZenWallStreetZen

NASDAQ: GNPX
Genprex Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for GNPX

Based on 1 analyst offering 12 month price targets for Genprex Inc.
Min Forecast
$10.00+350.65%
Avg Forecast
$10.00+350.65%
Max Forecast
$10.00+350.65%

Should I buy or sell GNPX stock?

Based on 1 analyst offering ratings for Genprex Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their GNPX stock forecasts and price targets.

GNPX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-04

1 of 1

Forecast return on equity

Is GNPX forecast to generate an efficient return?
Company
N/A
Industry
-59.45%
Market
20.1%

Forecast return on assets

Is GNPX forecast to generate an efficient return on assets?
Company
N/A
Industry
5.95%

GNPX revenue forecast

What is GNPX's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$150.0M

GNPX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GNPX$2.22$10.00+350.65%Buy
ENSC$0.58N/AN/A
KTRA$0.11N/AN/A
PALI$5.07$22.50+343.79%Strong Buy
SCPX$0.16N/AN/A
View Top Biotech Stocks

Genprex Stock Forecast FAQ

Is Genprex Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: GNPX) stock is to Buy GNPX stock.

Out of 1 analyst, 0 (0%) are recommending GNPX as a Strong Buy, 1 (100%) are recommending GNPX as a Buy, 0 (0%) are recommending GNPX as a Hold, 0 (0%) are recommending GNPX as a Sell, and 0 (0%) are recommending GNPX as a Strong Sell.

If you're new to stock investing, here's how to buy Genprex stock.

What is GNPX's revenue growth forecast for 2030-2030?

(NASDAQ: GNPX) Genprex's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 60.26%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.39%.

Genprex's revenue in 2024 is $0.

In 2030, GNPX is forecast to generate $286,566,150 in revenue, with the lowest revenue forecast at $286,566,150 and the highest revenue forecast at $286,566,150.

What is GNPX's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: GNPX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 5.95%.

What is GNPX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year GNPX price target, the average GNPX price target is $10.00, with the highest GNPX stock price forecast at $10.00 and the lowest GNPX stock price forecast at $10.00.

The Wall Street analyst predicted that Genprex's share price could reach $10.00 by Apr 4, 2025. The average Genprex stock price prediction forecasts a potential upside of 350.65% from the current GNPX share price of $2.22.

What is GNPX's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: GNPX) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.